Targeted Radiotherapy using CLIPS™ Macrocyclic Peptides: The case of PSV359
Time: 2:00 pm
day: P&T Track PM
Details:
- Discovery, development and preclinical study of [²¹²Pb] PSV359 macrocyclic peptide against FAPα protein
- Targeting tumor receptors with an on-cell macrocyclic peptide screening platform
- Macrocyclic CLIPS™ peptide discovery and optimization platform for radioligand therapy
